Cyclosporine: a new immunosuppressive agent for organ transplantationCOHEN, D. J; LOERTSCHER, R; RUBIN, M. F et al.Annals of internal medicine. 1984, Vol 101, Num 5, pp 667-682, issn 0003-4819Article

Cyclosporine abrogation of second-set rejection: dependence upon major histocompatibility complex disparitySCHULAK, J. A; ENGELSTAD, K.The Journal of surgical research. 1985, Vol 38, Num 4, pp 400-406, issn 0022-4804Article

Le cardiologue et les immunosuppresseurs = The cardiologist and immunosuppressive therapyAMBROSI, Pierre; LAFFORGUE, Pierre.La Presse médicale (1983). 2012, Vol 41, Num 6, pp 655-661, issn 0755-4982, 7 p.Conference Paper

Cyclosporine does not prevent in vivo expression of T cell activation antigens following allogeneic bone marrow transplantationFORMAN, S. J; GALLAGHER, M. T; ZAIA, J. A et al.Transplantation. 1984, Vol 37, Num 2, pp 219-220, issn 0041-1337Article

Cyclosporine ― A model for the testing of bio-immunological reaction modifiers in manPOWLES, R. L; EVANS, B; PEDRAZZINI, A et al.Medical oncology and tumor pharmacotherapy. 1984, Vol 1, Num 2, pp 137-139, issn 0736-0118Article

The effects of cyclosporin A on the induction, expression and regulation of the immune response to Herpes simplex virusALTMANN, D. M; BLYTH, W. A.Clinical and experimental immunology (Print). 1985, Vol 59, Num 1, pp 17-22, issn 0009-9104Article

Murine lupus nephritis: effects of cyclophosphamide on circulating and tissue bound immunoreactantsCAVALLO, T; GRAVES, K; GRANHOLM, N. A et al.Clinical and experimental immunology (Print). 1984, Vol 55, Num 1, pp 67-73, issn 0009-9104Article

Isolation of a factor from cancer ascitic fluid increasing susceptibility of mice to Listeria infectionTAKANO, S; UMENAI, T; TANAKA, K et al.Proceedings of the Society for Experimental Biology and Medicine. 1983, Vol 174, Num 1, pp 65-73, issn 0037-9727Article

Cyclosporin APAGE, E. H; WEXLER, D. M; GUENTHER, L. C et al.Journal of the American Academy of Dermatology. 1986, Vol 14, Num 5, pp 785-791, issn 0190-9622Article

The influence of cyclosporin A on the induction of experimental autoimmune thyroid disease in the PVG/c ratHASSMAN, R. A; DIEGUEZ, C; RENNIE, D. P et al.Clinical and experimental immunology (Print). 1985, Vol 59, Num 1, pp 10-16, issn 0009-9104Article

Effect of cyclosporin A and inhibitors of arachidonic acid metabolism on blood flow and cyclo-oxygenase products in rat skin allograftsFAN, T.-P. D; LEWIS, G. P.British journal of pharmacology. 1984, Vol 81, Num 2, pp 361-371, issn 0007-1188Article

Mechanisms of action and clinical applications of cyclosporin in organ transplantationROGERS, A. J; KAHAN, B. D.Clinics in immunology and allergy. 1984, Vol 4, Num 2, pp 217-258, issn 0260-4639Article

Modification of function and migration patterns of thymocyte populations by cyclosporine after organ transplantation in ratsKUPIEC-WEGLINSKI, J. W; LEAR, P. A; HEIDECKE, C. D et al.Transplantation. 1984, Vol 37, Num 6, pp 631-633, issn 0041-1337Article

FK 506SEWING, K.-F; CHRISTIANS, U.Lancet (British edition). 1991, Vol 337, Num 8739, issn 0140-6736, p. 499Article

Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosusTAKABAYASHI, K; KOIKE, T; KURASAWA, K et al.Clinical immunology and immunopathology (Print). 1989, Vol 51, Num 1, pp 110-117, issn 0090-1229, 8 p.Article

Prolongation of life in female NZB/NZW (F₁) hybrid mice by cyclosporin AJONES, M. G; HARRIS, G.Clinical and experimental immunology (Print). 1985, Vol 59, Num 1, pp 1-9, issn 0009-9104Article

Myasthenia gravis: reactivation of clinical disease and of autoimmune factors after discontinuation of long-term azathioprineHOHLFELD, R; TOYKA, K. V; BESINGER, U. A et al.Annals of neurology. 1985, Vol 17, Num 3, pp 238-242, issn 0364-5134Article

Inhibition of contact sensitivity reactions to DNFB by topical cyclosporin application in the guinea-pigALDRIDGE, R. D; THOMSON, A. W; RANKIN, R et al.Clinical and experimental immunology (Print). 1985, Vol 59, Num 1, pp 23-28, issn 0009-9104Article

Cyclosporine monitoringBURCKART, Gilbert J; CANAFAX, Daniel M; YEE, Gary C et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 7-8, pp 1277-1280, issn 1060-0280, 4 p.Article

INHIBITION OF INTERFERON OR SOLUBLE IMMUNE RESPONSE SUPPRESSOR (SIRS) MEDIATED SUPPRESSION BY LEVAMISOLEAUNE TM; PIERCE CW.1983; INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY; ISSN 0192-0561; USA; DA. 1983; VOL. 5; NO 1; PP. 91-98; BIBL. 30 REF.Article

IMMUNOSUPPRESSIVE ACTIVITY OF SUCCINYLACETONETSCHUDY DP; HESS RA; FRYKHOLM BC et al.1982; JOURNAL OF LABORATORY AND CLINICAL MEDICINE; ISSN 0022-2143; USA; DA. 1982; VOL. 99; NO 4; PP. 526-532; BIBL. 10 REF.Article

MURINE T CELL SUPPRESSION DEMONSTRABLE IN THE ABSENCE OF CYTOTOXICITY AND THE EFFECT OF CYCLOSPORIN A ON THIS SYSTEMHUTCHINGS PR; COOKE A; GUNN HC et al.1983; JOURNAL OF IMMUNOLOGY; ISSN 0022-1767; USA; DA. 1983; VOL. 130; NO 3; PP. 1071-1076; BIBL. 19 REF.Article

THE CELLULAR TARGET OF CYCLOSPORIN A ACTION IN HUMANSVAN BUREN CT; KERMAN R; AGOSTINO G et al.1982; SURGERY; ISSN 0039-6060; USA; DA. 1982; VOL. 92; NO 2; PP. 167-174; BIBL. 27 REF.Article

Le tacrolimus (FK 506) = Tracolimus (FK 506)MEUNIER, B; MORDELET, M. F; LEBERT, C et al.Journal de pharmacie clinique (Paris). 1996, Vol 15, Num 2, pp 99-105, issn 0291-1981Conference Paper

Tacrolimus : a new immunosuppressive agentKELLY, P. A; BURCKART, G. J; RAMAN VENKATARAMANAN et al.American journal of health-system pharmacy. 1995, Vol 52, Num 14, pp 1521-1535, issn 1079-2082Article